201 related articles for article (PubMed ID: 24223609)
21. Problematic detoxification of estrogen quinones by NAD(P)H-dependent quinone oxidoreductase and glutathione-S-transferase.
Chandrasena RE; Edirisinghe PD; Bolton JL; Thatcher GR
Chem Res Toxicol; 2008 Jul; 21(7):1324-9. PubMed ID: 18588320
[TBL] [Abstract][Full Text] [Related]
22. Hormone-modulating herbs: implications for women's health.
Wade C; Kronenberg F; Kelly A; Murphy PA
J Am Med Womens Assoc (1972); 1999; 54(4):181-3. PubMed ID: 10531758
[TBL] [Abstract][Full Text] [Related]
23. NAD(P)H:quinone oxidoreductase 1 Arg139Trp and Pro187Ser polymorphisms imbalance estrogen metabolism towards DNA adduct formation in human mammary epithelial cells.
Singh S; Zahid M; Saeed M; Gaikwad NW; Meza JL; Cavalieri EL; Rogan EG; Chakravarti D
J Steroid Biochem Mol Biol; 2009 Oct; 117(1-3):56-66. PubMed ID: 19628038
[TBL] [Abstract][Full Text] [Related]
24. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells.
Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD
Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384
[TBL] [Abstract][Full Text] [Related]
25. Potential mechanisms of estrogen quinone carcinogenesis.
Bolton JL; Thatcher GR
Chem Res Toxicol; 2008 Jan; 21(1):93-101. PubMed ID: 18052105
[TBL] [Abstract][Full Text] [Related]
26. Bioreductive activation of catechol estrogen-ortho-quinones: aromatization of the B ring in 4-hydroxyequilenin markedly alters quinoid formation and reactivity.
Shen L; Pisha E; Huang Z; Pezzuto JM; Krol E; Alam Z; van Breemen RB; Bolton JL
Carcinogenesis; 1997 May; 18(5):1093-101. PubMed ID: 9163701
[TBL] [Abstract][Full Text] [Related]
27. Polymorphisms in genes involved in estrogen and progesterone metabolism and mammographic density changes in women randomized to postmenopausal hormone therapy: results from a pilot study.
Lord SJ; Mack WJ; Van Den Berg D; Pike MC; Ingles SA; Haiman CA; Wang W; Parisky YR; Hodis HN; Ursin G
Breast Cancer Res; 2005; 7(3):R336-44. PubMed ID: 15987428
[TBL] [Abstract][Full Text] [Related]
28. A comparative review of the risks and benefits of hormone replacement therapy regimens.
Warren MP
Am J Obstet Gynecol; 2004 Apr; 190(4):1141-67. PubMed ID: 15118656
[TBL] [Abstract][Full Text] [Related]
29. A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives.
Hu Z; Song CG; Lu JS; Luo JM; Shen ZZ; Huang W; Shao ZM
J Cancer Res Clin Oncol; 2007 Dec; 133(12):969-78. PubMed ID: 17562079
[TBL] [Abstract][Full Text] [Related]
30. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2004; 11(1):11-33. PubMed ID: 14716179
[TBL] [Abstract][Full Text] [Related]
31. Soy isoflavones decrease the catechol-O-methyltransferase-mediated inactivation of 4-hydroxyestradiol in cultured MCF-7 cells.
Lehmann L; Jiang L; Wagner J
Carcinogenesis; 2008 Feb; 29(2):363-70. PubMed ID: 18192686
[TBL] [Abstract][Full Text] [Related]
32. Modulation of estrogen synthesis and metabolism by phytoestrogens
van Duursen MBM
Toxicol Res (Camb); 2017 Nov; 6(6):772-794. PubMed ID: 30090542
[TBL] [Abstract][Full Text] [Related]
33. Aromatase inhibitors and mammographic breast density in postmenopausal women receiving hormone therapy.
Mousa NA; Crystal P; Wolfman WL; Bedaiwy MA; Casper RF
Menopause; 2008; 15(5):875-84. PubMed ID: 18480735
[TBL] [Abstract][Full Text] [Related]
34. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
Banks E; Canfell K
Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
[TBL] [Abstract][Full Text] [Related]
35. A molecular docking study of phytochemical estrogen mimics from dietary herbal supplements.
Powers CN; Setzer WN
In Silico Pharmacol; 2015; 3():4. PubMed ID: 25878948
[TBL] [Abstract][Full Text] [Related]
36. Hormone Therapy and Other Treatments for Symptoms of Menopause.
Hill DA; Crider M; Hill SR
Am Fam Physician; 2016 Dec; 94(11):884-889. PubMed ID: 27929271
[TBL] [Abstract][Full Text] [Related]
37. Physicians' and women's views on hormone therapy and breast cancer risk after the WHI: a qualitative study.
Nekhlyudov L; Bush T; Bonomi AE; Ludman EJ; Newton KM
Women Health; 2009 Jun; 49(4):280-93. PubMed ID: 19753504
[TBL] [Abstract][Full Text] [Related]
38. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
[TBL] [Abstract][Full Text] [Related]
39. Menopausal hormone therapy.
Bhavnani BR; Strickler RC
J Obstet Gynaecol Can; 2005 Feb; 27(2):137-62. PubMed ID: 15937590
[TBL] [Abstract][Full Text] [Related]
40. Regulation of cancer-related genes - Cyp1a1, Cyp1b1, Cyp19, Nqo1 and Comt - expression in β-naphthoflavone-treated mice by miroestrol.
Chatuphonprasert W; Jarukamjorn K; Putalun W
J Pharm Pharmacol; 2016 Apr; 68(4):475-84. PubMed ID: 26893163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
